本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Standard BioTools Inc.

1.35
-0.0200-1.46%
盘后1.350.00000.00%16:13 EDT
成交量:86.04万
成交额:115.04万
市值:5.13亿
市盈率:-3.81
高:1.39
开:1.38
低:1.31
收:1.37
数据加载中...
2024/01/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/20

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/01/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/30

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/12/30

重要事件披露

Form 8-K - Current report
2023/12/26

重要事件披露

Form 8-K - Current report
2023/12/26

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/12/20

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/04

重要事件披露

Form 8-K - Current report
2023/12/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/12/01

SEC问询函

Form CORRESP - Correspondence
2023/11/29

重要事件披露

Form 8-K - Current report
2023/11/29

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/11/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]